Chitosan-Based Nose-to-Brain Drug Delivery for Management of Neurological Disorders: Intrinsic Neuroprotective Action and Carrier Capabilities.

Singh A, Bhukta S, Mishra D, Palei NN, Verma A, Mohapatra L

Open source

DOI
10.1208/s12249-026-03563-8
Published
2026 Sep 30
Container
AAPS PharmSciTech
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1208/s12249-026-03563-8,
  title = {Chitosan-Based Nose-to-Brain Drug Delivery for Management of Neurological Disorders: Intrinsic Neuroprotective Action and Carrier Capabilities.},
  author = {Singh A and Bhukta S and Mishra D and Palei NN and Verma A and Mohapatra L},
  year = {2026},
  journal = {AAPS PharmSciTech},
  doi = {10.1208/s12249-026-03563-8},
  url = {https://doi.org/10.1208/s12249-026-03563-8}
}

RIS

TY  - JOUR
TI  - Chitosan-Based Nose-to-Brain Drug Delivery for Management of Neurological Disorders: Intrinsic Neuroprotective Action and Carrier Capabilities.
AU  - Singh A
AU  - Bhukta S
AU  - Mishra D
AU  - Palei NN
AU  - Verma A
AU  - Mohapatra L
PY  - 2026
JO  - AAPS PharmSciTech
DO  - 10.1208/s12249-026-03563-8
UR  - https://doi.org/10.1208/s12249-026-03563-8
ER  - 

APA

A, S., S, B., D, M., NN, P., A, V., & L, M. (2026). Chitosan-Based Nose-to-Brain Drug Delivery for Management of Neurological Disorders: Intrinsic Neuroprotective Action and Carrier Capabilities.. AAPS PharmSciTech. https://doi.org/10.1208/s12249-026-03563-8

Source records